RxDoctor Payments Data

Christina Leyson, MD

Gastroenterology · Lexington, KYNPI 1063650604

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (41.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Sirtex Medical Inc at 41.3% of the total. That places this record below the midpoint for gastroenterology clinicians in KY, where the typical reported total is $3,388.

$3,149in general payments, 2019–2025

Across 13 payments — averaging $242.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sirtex Medical Inc$1K
  • Novo Nordisk AS$1K
  • Mallinckrodt Hospital Products Inc.$339
  • Madrigal Pharmaceuticals$322
  • Novo Nordisk$125
  • AbbVie$19
$53,868in research payments, 2019–2025

Across 85 payments — averaging $633.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novo Nordisk AS$54K

What the payments were for

  • Consulting fees$1,30041%
  • Travel & lodging$1,04433%
  • Food & beverage$80526%

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,149 in reported general payments places this provider in the 45th percentile of 207 gastroenterology providers in Kentucky.

See all gastroenterology providers in Kentucky

Medicare billing

Part B allowed, 2024
$39,455
Medicare patients
159
Services billed
326

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XifaxanRifaximin191$576,164
VemlidyTenofovir Alafenamide20$37,830
LokelmaSodium Zirconium Cyclosilicate11$19,369
Everolimus14$14,449
Envarsus XrTacrolimus19$13,680
Tacrolimus128$11,934
Ursodiol46$6,793
Mycophenolate Mofetil83$5,802
Valganciclovir Hcl17$3,870
Lactulose47$3,190
Midodrine Hcl16$1,566
Entecavir13$1,054
Spironolactone71$765
Budesonide DrBudesonide19$652
Bumetanide19$411

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →